Levin Pharma Limited has announced its first successful export to the Arab region, which has marketing an important milestone in the company’s growth strategy.
The development was revealed in a notice to the Pakistan Stock Exchange (PSX) on Thursday.
According to the company, the export order was received last year and has now been completed, which paved the way for further expansion of international markets.
In a related move, Levin Pharma last monthly intentions revealed that it would collect Rs 200 million in the issue of strengthening its financial position and the rights of the future business growth.
The company will release 20 million common shares of Rs 10 per share, which will represent about 21 21.5 % of its current paid investment. At the end of share transfer books, shares of every 100 common shares are translated by shares of 21.496 rights for every 100 common shares.
On October 21, 1991, he was added to Pakistan as a private limited company, leavan pharma became common on April 30, 1992 under the Ordinance of the Companies, 1984 (now the Companies Act, 2017).
Its main business is to produce pharmaceuticals and its affiliated products.